Barclays
GNLX icon

Barclays’s Genelux GNLX Stock Holding History

Barclays’s Portfolio GNLX Stock Details GNLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$801 Sell
266
-32,490
-99% -$91.9K ﹤0.01% 4953
2026
Q1 		$79.3K Sell
32,756
-49,848
-60% -$136K ﹤0.01% 4130
2025
Q4 		$360K Buy
+82,604
New +$446K ﹤0.01% 4037
2024
Q3 		– Sell
-15,138
Closed -$29.5K – 5359
2024
Q2 		$29.5K Buy
15,138
+1,710
+13% +$5.81K ﹤0.01% 4363
2024
Q1 		$86.3K Sell
13,428
-12,037
-47% -$109K ﹤0.01% 4480
2023
Q4 		$357K Buy
25,465
+22,081
+653% +$349K ﹤0.01% 4097
2023
Q3 		$82.9K Buy
3,384
+2,835
+516% +$71.8K ﹤0.01% 3665
2023
Q2 		$18K Sell
549
-32,629
-98% -$918K ﹤0.01% 4151
2023
Q1 		$920K Buy
+33,178
New +$538K ﹤0.01% 2792

Other funds holding GNLX

WDC
Woodward Diversified Capital Bakersfield, California $227M AUM 40.62% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM

Barclays's GNLX Position: Q2 2026 in Review

Barclays reduced its Genelux (GNLX) stake by 99% in Q2 2026, selling an estimated $91.9K and leaving 266 shares worth $801. The position accounts for ﹤0.01% of the portfolio, ranked #4953.

Barclays first reported a position in GNLX in Q1 2023 and has held it in 9 quarters since. The position peaked at $920K in Q1 2023. 72 funds tracked by Wall St. Rank hold GNLX as of Q2 2026.

  • Barclays held 266 shares of Genelux worth $801 as of Q2 2026.
  • Barclays sold 32,490 Genelux shares in Q2 2026, an estimated $91.9K.
  • Genelux made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4953 holding.
  • Barclays first reported a position in Genelux in Q1 2023 and has held it in 9 quarters since.
  • Barclays's Genelux position peaked at $920K in Q1 2023.
  • 72 funds tracked by Wall St. Rank held Genelux as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.